News & Events

News

May 04, 2023

MMIT Announces Winners of the Eighth-Annual Specialty Pharmacy Patient Choice Awards

May 4, 2023, Yardley, PA – Today Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner for overcoming barriers to patient access, announced the winners of its eighth-annual Specialty Pharmacy Patient Choice Awards.

Apr 11, 2023

MMIT Announces Finalists of the Eighth-Annual Specialty Pharmacy Patient Choice Awards

April 11, 2023, Yardley, PA – Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner for overcoming barriers to patient access, has announced the finalists of its eighth Specialty Pharmacy Patient Choice Awards.

Mar 30, 2023

MMIT Announces the Winners of the Q4 2022 Patient Access Awards

March 30, 2023, Yardley, PA – Managed Markets Insight & Technology (MMIT), the leading provider of market access data, analytics and insights, has announced the winners of its quarterly Patient Access Awards, which honor manufacturers committed to improving patient access to life-saving therapies.

View All

Slide 1

Upcoming Events

October 16-19

AMCP Nexus

Meet MMIT at AMCP Nexus, Orlando, Fl, October 16-19, 2023. Nexus brings together a diverse group of payers, pharmacy benefit managers, integrated delivery systems, health economists and analysts, patient advocates, academicians, pharmaceutical manufacturers, and other key stakeholders.

Days

Hours

Minutes

Seconds

In the Media

STAT

Drug Channels

How Payers Are Reacting to Insulin Price Changes

September 15, 2023

Insulin price caps and list price reductions are a huge step forward for patient access. But what will these changes mean for health plans?

Drug Channels

Contract Pharma

Solving Pharma’s Underlying Rebate Leakage Problem

September 13, 2013

Rebate leakage drains millions in revenue from pharma companies every year. To ensure contract compliance, manufacturers can implement these five steps.

Drug Channels

White Bagging Update 2023: Saving Money or Shifting Costs?

September 13, 2013

Buy-and-bill remains the most common distribution channel for provider-administered oncology drugs, but pharmacy channels are still significant, especially for hospital outpatient departments.

STAT

Uncovering the Patient Journey: Four Ways Real-World Data Offers Value

September 12, 2023

Infusing a commercialization strategy with real-world data provides a more holistic view of the patient journey.

Modern Healthcare

Helping payers and providers grow amid volatility: Leveraging data to improve the care experience

July 1, 2023

Preliminary data indicate that 2023 may prove to be the most volatile year for health plan enrollment in a decade.

Biopharma Dive

BioPharma Dive

Pfizer’s RSV Vaccine Wins FDA Approval in Older Adults

May 31, 2023

The shot’s clearance comes several weeks after the regulator made GSK’s Arexvy the first vaccine for RSV in the U.S.

BioPharma Dive

How Real-World Data Helps Manufacturers See the Complete Market Access Story

May 15, 2023

Over the past few decades, pharma companies have perfected the art of using market access data to support product launches, negotiate payer discounts, and secure preferred status and positioning.

Consumer Affairs

Can Anything Be Done to Bring Down Prescription Drug Costs?

May 5, 2023

The Senate Health, Education, Labor and Pensions (HELP) Committee went to work this week to find a bipartisan consensus on measures to reduce prescription drug costs.

Pharmacy Times

Pharamacy Times

Adult Vaccinations and Decentralization of Health Care: How to Navigate the Landscape

May 5, 2023

Vaccination is especially important for older adults with any chronic health conditions because vaccines can prevent serious illness and resulting complications down the road.

Drug Channels

Press Release

MMIT Announces Finalists of the Eighth-Annual Specialty Pharmacy Patient Choice Awards

April 11, 2023

Twelve specialty pharmacies recognized for their dedication to top-quality customer service.

Fierce Healthcare

Staying Competitive in an Expanding Medicare Advantage Market

March 13, 2023

By the end of 2023, more than half of the total Medicare population is expected to be enrolled in Medicare Advantage (MA), which has climbed from 25.2 million members in 2020 to 31.5 million members today.

Drug Channels

Copay Accumulator and Maximizer Update: Adoption Plateaus as Insurers Battle Patients Over Copay Support

February 22, 2023

Our latest update finds that for 2022, about 40% of commercial lives have adopted these benefit designs.

Healthline

Biosimilar Drugs to Humira Are Arriving: Why Prices Won't Be Significantly Lower

February 3, 2023

Humira, the best-selling drug used to treat multiple forms of arthritis and other conditions such as ulcerative colitis and Crohn’s disease, finally has some competition.

Drug Channels

The Evolution of Medical Benefit Contracting: How Pharma Can Prepare

January 27, 2023

Given the growth of specialty pharmaceuticals, manufacturers will need to develop more aggressive contracting strategies to secure optimal market access for their medical benefit drugs.

Formulary Watch

Analysis: Payers Restrict Medications for Autoimmune Diseases

January 26, 2023

Health insurance plans and PBMs receive poor grades for ensuring access to medications for patients living with autoimmune diseases, according to a newly released scorecard.

Drug Discovery World

What will the 2023 drug discovery landscape look like?

January 24, 2023

DDW Multimedia Editor Megan Thomas observes the 2023 drug discovery landscape, speaking to industry experts and looking at the foundations of 2022 on which next year will lean.

Formulary Watch

ICER Review Leads to Formulary Changes

January 17, 2023

While ICER found that overall major payer coverage policies are in line with the organization’s fair access criteria, many payers do not provide adequate transparency into clinical coverage criteria.

Drug Channels

What Pharma Companies Can Expect From the Influx of Humira Biosimilars

October 14, 2022

Next year’s staggered launch of adalimumab biosimilars will mark one of the largest losses of exclusivity for a pharmaceutical company in U.S. market history.

Fierce Pharma

How Real-World Data Can Help Maximize Patient Access

October 3, 2022

When faced with launching its new product, one midsized pharma manufacturer’s marketing team needed an innovative way to quickly identify and geographically target the right cohort of patients for their highly specialized therapy.

Fierce Healthcare

The End of the COVID-19 Public Health Emergency Is Inevitable. Here’s What That Could Mean for Health Plans

August 1, 2022

With the continuation of the COVID-19 pandemic and resulting policy changes, the health plan landscape is facing some complex challenges ahead.

Get an Actionable Understanding of the Business of Healthcare and Pharmaceuticals

Subscribe Today!

Get the latest news, press releases and event info from MMIT.